Showing 361-370 of 3011 results for "".
The Complex and Heterogeneous Pathophysiology of Atopic Dermatitis: Many Facets of Disease
https://practicaldermatology.com/topics/atopic-dermatitis/the-complex-and-heterogeneous-pathophysiology-of-atopic-dermatitis-many-facets-of-disease/23912/Optimizing Isotretinoin Treatment: Keys to Successful Prescribing and Management
https://practicaldermatology.com/topics/practice-management/optimizing-isotretinoin-treatment-keys-to-successful-prescribing-and-management/21193/Embraced by the dermatology community, isotretinoin is still considered controversial by some patients. Here are tips on navigating the prescribing process to improve patient comfort and adherence.Evolving Perspectives: The Dermatology M&A Market in Today’s Environment
https://practicaldermatology.com/topics/practice-management/evolving-perspectives-the-dermatology-ma-market-in-todays-environment/23945/Halfway through 2023: The trends and emerging insights in the dermatology and aesthetics industries.Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.Slimming the Masseters with Neuromodulator Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/slimming-the-masseters-with-neuromodulator-injections/23648/Demand for this minimally-invasive and effective intervention is growing. Success depends on proper training and administration.Content Marketing for Dermatologists
https://practicaldermatology.com/topics/practice-management/content-marketing-for-dermatologists/20536/A mix of time-sensitive and evergreen content is best to optimize engagement.Practice Makes…More Practice
https://practicaldermatology.com/topics/psoriasis/practice-makesmore-practice/20347/Go Big or Go Home? Taking MIPS to The Max
https://practicaldermatology.com/topics/practice-management/go-big-or-go-home-taking-mips-to-the-max/20696/Part three in a three-part series on the MIPS “pick-your-pace” transition.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesGoing Digital: Marketing for the 21st Century
https://practicaldermatology.com/topics/practice-management/going-digital-marketing-for-the-21st-century/22911/Efficient analysis and use of practice data will generate much larger returns on investment for aesthetic and medical practices.